Transition report pursuant to Rule 13a-10 or 15d-10

Income Taxes - Schedule of Deferred Tax Assets (Details)

v3.21.1
Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2020
Mar. 31, 2020
Income Tax Disclosure [Abstract]    
Net operating loss $ 28,914,000 $ 8,127,000
Research and development credit 5,464,000 2,012,000
Accrued expenses 292,000 348,000
Patent 422,000
Impairment loss 361,000
Stock compensation 2,654,000
Other 84,000 56,000
Total deferred income tax assets 38,191,000 10,543,000
Fixed assets 44,000 (9,000)
Intangible assets (18,000) (22,000)
Total deferred income tax liabilities 26,000 (31,000)
Net deferred income tax assets 38,217,000 10,512,000
Valuation allowance (38,217,000) (10,512,000)
Net deferred tax assets